Dermatology · Farmington, CT
NPI
1417099128
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
21 South Rd, Dermatology
Farmington, CT, 06032
Phone (860) 679-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
1,331 services
Medicare patients, 2024
365
Average age 73
Drug cost, 2024
$3.5M
1,493 prescriptions
Company payments, 2025
$19K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jun Lu was code 17003 (destruction skin lesion), 308 times for 69 patients. In total Jun Lu billed 1,331 services in 28 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 308 | 69 | $1.51 | $464 |
| 17003 Destruction Skin Lesion | Facility | 207 | 38 | $1.57 | $326 |
| 99213 Office E&M - Established | Office | 151 | 137 | $43.69 | $6,598 |
| 99213 Office E&M - Established | Facility | 98 | 95 | $48.18 | $4,722 |
| 17000 Destruction Skin Lesion | Office | 91 | 84 | $40.09 | $3,648 |
| 99214 Office E&M - Established | Facility | 86 | 65 | $64.37 | $5,536 |
| 99214 Office E&M - Established | Office | 68 | 60 | $66.09 | $4,494 |
| 17000 Destruction Skin Lesion | Facility | 56 | 49 | $39.30 | $2,201 |
| 17110 Destruction Skin Lesion | Office | 32 | 30 | $45.23 | $1,447 |
| 11102 Skin Biopsy | Office | 29 | 28 | $14.91 | $432 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 27 | 17 | $12.95 | $350 |
| 11102 Skin Biopsy | Facility | 26 | 26 | $19.89 | $517 |
| 17110 Destruction Skin Lesion | Facility | 24 | 19 | $53.17 | $1,276 |
| 99204 Office E&M - New | Facility | 17 | 17 | $78.15 | $1,328 |
| 99203 Office E&M - New | Facility | 15 | 15 | $58.03 | $870 |
By year: 2022 $42K for 1,350 services; 2023 $37K for 1,161 services; 2024 $38K for 1,331 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jun Lu prescribed most often to Medicare patients was Ketoconazole, with 151 prescriptions and refills. In total Jun Lu wrote 1,493 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 151 | 164 | 68 | $2,001 |
| Triamcinolone Acetonide Generic | 100 | 112 | 73 | $900 |
| Clobetasol Propionate Generic | 90 | 95 | 40 | $4,421 |
| Hydrocortisone Generic | 69 | 71 | 45 | $449 |
| Dupixent Syringe Dupilumab | 62 | 69 | Under 11 | $285K |
| Metronidazole Generic | 60 | 70 | 29 | $2,347 |
| Humira(Cf) Pen Adalimumab | 59 | 68 | 11 | $483K |
| Clindamycin Phosphate Generic | 55 | 63 | 25 | $1,635 |
| Betamethasone Dipropionate Generic | 39 | 39 | 23 | $1,451 |
| Skyrizi Risankizumab-Rzaa | 37 | 94 | 12 | $792K |
| Otezla Apremilast | 35 | 43 | Under 11 | $206K |
| Hydroxychloroquine Sulfate Generic | 33 | 62 | Under 11 | $416 |
| Calcipotriene Generic | 33 | 33 | 17 | $3,006 |
| Opzelura Ruxolitinib Phosphate | 33 | 33 | 12 | $63K |
| Fluorouracil Generic | 29 | 29 | 25 | $1,867 |
Brand drugs: 483 claims; generic drugs: 1,010 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jun Lu $19K ($19K in general payments such as food, travel and fees) from 12 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.